Biomarkers of Antiangiogenic Therapy: How Do We Move From Candidate Biomarkers to Valid Biomarkers

被引：35

作者：

Duda, Dan G. ^{[1
]}

Ancukiewicz, Marek

Jain, Rakesh K.

机构：

[1] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 02期

关键词：

VASCULAR NORMALIZATION; KINASE INHIBITOR; BEVACIZUMAB; CANCER; VANDETANIB; PACLITAXEL; FLUOROURACIL; CARBOPLATIN; METASTASIS; LEUCOVORIN;

D O I：

10.1200/JCO.2009.24.8021

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

页码：183 / 185

页数：3

共 24 条

[1]

AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients [J].

Batchelor, Tracy T. ;

Sorensen, A. Gregory ;

di Tomaso, Emmanuelle ;

Zhang, Wei-Ting ;

Duda, Dan G. ;

Cohen, Kenneth S. ;

Kozak, Kevin R. ;

Cahill, Daniel P. ;

Chen, Poe-Jou ;

Zhu, Mingwang ;

Ancukiewicz, Marek ;

Mrugala, Maciej M. ;

Plotkin, Scott ;

Drappatz, Jan ;

Louis, David N. ;

Ivy, Percy ;

Scadden, David T. ;

Benner, Thomas ;

Loeffler, Jay S. ;

Wen, Patrick Y. ;

Jain, Rakesh K. .

CANCER CELL, 2007, 11 (01) :83-95

[2]

Dowlati A, 2006, J CLIN ONCOL, V24, p370S

[3]

Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis [J].

Ebos, John M. L. ;

Lee, Christina R. ;

Cruz-Munoz, William ;

Bjarnason, Georg A. ;

Christensen, James G. ;

Kerbel, Robert S. .

CANCER CELL, 2009, 15 (03) :232-239

[4]

Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: Results from the Eastern Cooperative Oncology Group Study E3200 [J].

Giantonio, Bruce J. ;

Catalano, Paul J. ;

Meropol, Neal J. ;

O'Dwyer, Peter J. ;

Mitchell, Edith P. ;

Alberts, Steven R. ;

Schwartz, Michael A. ;

Benson, Al B., III .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (12) :1539-1544

[5]

Vascular normalization in Rgs5-deficient tumours promotes immune destruction [J].

Hamzah, Juliana ;

Jugold, Manfred ;

Kiessling, Fabian ;

Rigby, Paul ;

Manzur, Mitali ;

Marti, Hugo H. ;

Rabie, Tamer ;

Kaden, Sylvia ;

Groene, Hermann-Josef ;

Haemmerling, Guenter J. ;

Arnold, Bernd ;

Ganss, Ruth .

NATURE, 2008, 453 (7193) :410-U67

[6]

Distinct Patterns of Cytokine and Angiogenic Factor Modulation and Markers of Benefit for Vandetanib and/or Chemotherapy in Patients With Non-Small-Cell Lung Cancer [J].

Hanrahan, Emer O. ;

Lin, Heather Y. ;

Kim, Edward S. ;

Yan, Shaoyu ;

Du, Danny Z. ;

McKee, Kathryn S. ;

Tran, Hai T. ;

Lee, J. Jack ;

Ryan, Anderson J. ;

Langmuir, Peter ;

Johnson, Bruce E. ;

Heymach, John V. .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (02) :193-201

[7]

Baseline Vascular Endothelial Growth Factor Concentration as a Potential Predictive Marker of Benefit from Vandetanib in Non-Small Cell Lung Cancer [J].

Hanrahan, Emer O. ;

Ryan, Anderson J. ;

Mann, Helen ;

Kennedy, Sarah J. ;

Langmuir, Peter ;

Natale, Ronald B. ;

Herbst, Roy S. ;

Johnson, Bruce E. ;

Heymach, John V. .

CLINICAL CANCER RESEARCH, 2009, 15 (10) :3600-3609

[8]

Randomized Phase II Study of Vandetanib Alone or With Paclitaxel and Carboplatin as First-Line Treatment for Advanced Non-Small-Cell Lung Cancer [J].

Heymach, John V. ;

Paz-Ares, Luis ;

De Braud, Filippo ;

Sebastian, Martin ;

Stewart, David J. ;

Eberhardt, Wilfried E. E. ;

Ranade, Anantbhushan A. ;

Cohen, Graham ;

Trigo, Jose Manuel ;

Sandler, Alan B. ;

Bonomi, Philip D. ;

Herbst, Roy S. ;

Krebs, Annetta D. ;

Vasselli, James ;

Johnson, Bruce E. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (33) :5407-5415

[9]

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer [J].

Hurwitz, H ;

Fehrenbacher, L ;

Novotny, W ;

Cartwright, T ;

Hainsworth, J ;

Heim, W ;

Berlin, J ;

Baron, A ;

Griffing, S ;

Holmgren, E ;

Ferrara, N ;

Fyfe, G ;

Rogers, B ;

Ross, R ;

Kabbinavar, F .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (23) :2335-2342

[10]

A New Target for Tumor Therapy [J].

Jain, Rakesh K. .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (25) :2669-2671

← 1 2 3 →